Valuation: Lifecare ASA

Market Cap 9.09Cr 97.39L 83.54L 78.01L 71.57L 1.35Cr 93Cr 1.37Cr 9.21Cr 3.6Cr 47Cr 3.66Cr 3.58Cr 154.37Cr P/E 2026 *
-0.87x
P/E 2027 * -1.91x
Enterprise Value 8.19Cr 87.75L 75.27L 70.29L 64.49L 1.21Cr 84Cr 1.23Cr 8.29Cr 3.25Cr 42Cr 3.29Cr 3.22Cr 139.09Cr EV / Sales 2026 *
-
EV / Sales 2027 * -
Free-Float
89.66%
Yield 2026 *
-
Yield 2027 * -
1 day-3.79%
1 week-5.43%
Current month-8.13%
1 month+7.02%
3 months-18.34%
6 months-27.03%
Current year-90.64%
1 week 0.29
Extreme 0.292
0.36
1 month 0.28
Extreme 0.2825
0.38
Current year 0.27
Extreme 0.27
1.99
1 year 0.27
Extreme 0.27
14.7
3 years 0.27
Extreme 0.27
82.16
5 years 0.27
Extreme 0.27
82.16
10 years 0.27
Extreme 0.27
117
Manager TitleAgeSince
Chief Executive Officer 50 07/09/2020
Director of Finance/CFO - 01/04/2026
Corporate Officer/Principal - 01/03/2024
Director TitleAgeSince
Director/Board Member - 26/06/2020
Chairman - 08/05/2021
Director/Board Member - 20/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
-3.79%-5.43%-98.02%-98.78% 1Cr
+2.37%+0.66%+4.21%+22.74% 4.86TCr
-0.62%+4.58%+487.47%+618.65% 4.63TCr
+2.09%+4.96%+20.59%+92.16% 4.2TCr
+3.85%+3.13%+29.60%+16.29% 3.95TCr
-0.72%-7.79%+17.87%+47.98% 3.17TCr
+3.04%+1.89%+31.62%+147.28% 1.65TCr
+4.33%+1.63% - - 1.63TCr
+1.44%+1.09%+4.93%+31.00% 1.4TCr
+3.87%+1.98%+82.99%+44.34% 1.33TCr
Average +1.42%-0.71%+64.58%+102.41% 2.68TCr
Weighted average by Cap. +1.77%-0.05%+107.43%+155.70%

Financials

2026 *2027 *
Net sales - -
Net income -11Cr -1.17Cr -1Cr -93.52L -85.8L -1.61Cr -111.59Cr -1.64Cr -11Cr -4.32Cr -56Cr -4.38Cr -4.29Cr -185.05Cr -6.7Cr -71.77L -61.56L -57.48L -52.74L -99.18L -69Cr -1.01Cr -6.78Cr -2.66Cr -34Cr -2.69Cr -2.64Cr -113.75Cr
Net Debt -90L -10L -8L -8L -7L -13.32L -9.21Cr -13.54L -91.11L -35.68L -4.62Cr -36.2L -35.41L -15Cr 40L 4L 4L 3L 3L 6L 4.1Cr 6L 40.49L 15.86L 2.05Cr 16.09L 15.74L 6.79Cr
Logo Lifecare ASA
Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
Employees
25
Date Price Change Volume
19/26/19 NOK 0.3050 -3.79% 1,54,95,546
18/26/18 NOK 0.3170 +0.63% 13,25,809
17/26/17 NOK 0.3150 -0.94% 7,68,124
14/26/14 NOK 0.3180 -0.63% 8,76,442
13/26/13 NOK 0.3200 +0.31% 16,63,237

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIFE Stock